01—Abstract
Summary
Summary of the 10-Q filed October 31, 2024. Cited figures are marked; the original filing is the authoritative source.
HCA Healthcare's third quarter 2024 results showed strong top-line and earnings growth.
Revenues rose 7.9% year over year to $17.487 billiona, driven by a 5.0% increase in equivalent admissions and a 2.8% increase in revenue per equivalent admission. Net income attributable to HCA rose 17.7% to $1.270 billion, or $4.88 per diluted share (versus $3.91). Income before taxes grew 17.0% to $1.906 billion, with salaries and benefits falling to 45.0% of revenue from 46.6%, helped by a 17.8% decline in contract labor.
Offsetting this, supplies, other operating expenses and interest expense were higher as a share of revenue or in absolute terms, and the quarter absorbed about $50 millionb (about $0.15 per diluted share) of Hurricane Helene costs. For the first nine months, revenues increased 9.8% to $52.318 billion and diluted EPS reached $16.37, up from $13.07. Operating cash flow improved to $7.955 billion from $6.757 billion, while capital expenditures held near $3.6 billion with about $5 billion planned for 2024.
Share repurchases were significant at $4.342 billionc year to date, and the company retired about 13 million shares, reducing the share count by roughly 6% year over year. Management expects Hurricane Helene and Hurricane Milton to cost $200 million to $300 million ($0.60 to $0.90 per diluted share) in the fourth quarter, before any insurance recoveries. Balance sheet leverage rose modestly.
Total debt reached $42.965 billiond, up from $39.593 billion at year-end 2023, following $7.5 billion of new senior notes issued in 2024 to refinance the asset-based revolver and fund the maturity of $2.0 billion of 2024 notes. Stockholders' deficit attributable to HCA widened to $(2.182) billion, a function of the buybacks and dividends exceeding retained earnings.
Liquidity remains solid, with $7.986 billion available under senior secured credit facilities and $2.888 billion of cash. The company also disclosed that its Florida and Texas hospitals represent 59% of admissions and 51% of revenue, concentrating exposure in two states.
02—Key points
Key Highlights
- Revenue grew 7.9% to $17.487 billion in Q3 2024, with equivalent admissions up 5.0% and revenue per equivalent admission up 2.8%.
- Q3 2024 diluted EPS of $4.88 rose from $3.91 (up roughly 25%), supported by lower contract labor costs and a 2.4% lower salaries-and-benefits ratio.
- Nine-month diluted EPS was $16.37 versus $13.07, with a $209 million pretax gain on a California hospital sale contributing $0.61 per share.
- Operating cash flow for the nine months rose to $7.955 billion from $6.757 billion, while $3.59 billion was spent on capital expenditures.
- Share repurchases totaled $4.342 billion year to date, reducing shares outstanding to 254.5 million from 265.5 million at year-end 2023.
- Hurricane Helene and Milton are expected to reduce Q4 2024 results by $200 million to $300 million ($0.60 to $0.90 per diluted share) before insurance recoveries.
- Total debt increased to $42.965 billion, with stockholders' deficit attributable to HCA widening to $(2.182) billion; the company issued $7.5 billion of new senior notes in 2024.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ3 FY2024filed October 31, 2024Financial Statements
Q3 FY2024 against Q3 FY2023
| Line item | Q3 FY2024Q3 FY2023 | Change |
|---|---|---|
| Revenue | $17.49B$16.21B | +7.9% |
| Operating Expenses | $15.58B$14.58B | +6.8% |
| Interest Expense | $515.00M$483.00M | +6.6% |
| Net Income | $1.27B$1.08B | +17.7% |
| EPS (Basic) | $4.94$3.98 | +24.1% |
| EPS (Diluted) | $4.88$3.91 | +24.8% |
| Shares Outstanding (Basic) | 256.76M271.17M | −5.3% |
| Shares Outstanding (Diluted) | 259.92M275.42M | −5.6% |
05—Questions
Frequently Asked Questions
What drove HCA's strong third quarter 2024 earnings growth?
Growth came mainly from higher patient volumes and pricing. Equivalent admissions rose 5.0% and revenue per equivalent admission rose 2.8%, lifting revenues 7.9%. Salaries and benefits fell to 45.0% of revenue from 46.6%, largely because contract labor declined 17.8%, which allowed pretax income to rise 17.0% and diluted EPS to reach $4.88 versus $3.91.
How significant are the hurricane-related costs for HCA?
Hurricane Helene cost roughly $50 million (about $0.15 per diluted share) in Q3 2024. Management expects an additional $200 million to $300 million ($0.60 to $0.90 per share) in Q4 2024 from Helene's impact on North Carolina facilities and Hurricane Milton's impact on Florida. These estimates exclude any insurance recoveries, so the net impact could be lower.
Is HCA's rising debt a concern for investors?
Total debt increased to $42.965 billion from $39.593 billion at year-end 2023, and interest expense rose to $1.533 billion for nine months from $1.447 billion. Management says cash flows, $7.986 billion of available credit facilities, and access to debt markets are sufficient for foreseeable liquidity needs. Most debt is fixed-rate (about $41.7 billion), so a 1% rate increase would reduce pretax earnings by only about $13 million annually.
How is HCA returning capital to shareholders?
HCA repurchased $4.342 billion of stock in the first nine months of 2024 and about 13.1 million shares, with $2.433 billion of authorization remaining. It also paid $525 million in dividends year to date and declared a $0.66 quarterly dividend in October 2024. The buybacks drove the diluted share count down to 259.9 million in Q3 from 275.4 million a year earlier.
What risks does HCA's revenue concentration pose?
Hospitals in Texas and Florida (98 facilities) generated 59% of admissions and 51% of revenue in Q3 2024, and they accounted for 74% of uninsured admissions. Government programs are a significant revenue source, and changes to Medicaid supplemental payments or federal health policy could affect results. Management also noted that a May 2024 CMS rule on state directed payments could lead to restructuring of these programs, though it could not estimate the financial impact.
06—Continue